Last updated: 2026-09-16 09:04:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Pulse Biosciences, Inc. (PLSE) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $56.75, with a market capitalisation of $3.87B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $12.56 to $58.90. This page covers its latest market performance, valuation, price trends and company information.
$3.87B | |
$55.15 | |
$58.90 | |
$1.18 | |
$55.20 | |
44.00 | |
461.05K | |
-- | |
$58.90 | |
$12.56 | |
-- | |
-- |
Pulse Biosciences, Inc. (PLSE) is trading at $56.75 in pre-market trading as of 2026-09-16 08:46:00, up 2.81% ($1.55) from the previous close of $55.20
Pre-market trading shows how investors are pricing PLSE before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, Pulse Biosciences, Inc. (PLSE) moved from $53.24 to $56.75, representing a gain of 6.60% ($3.51).
The stock traded between $47.70 and $58.90 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 771.97 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 95.4%
PLSE is currently trading at $56.75, placing it 95.4% of the way from its 52-week low of $12.56 to its 52-week high of $58.90. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 116 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Pulse Biosciences, Inc. (PLSE) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.